Weight-based dosing of pembrolizumab every 6 weeks in the time of COVID-19 Editorial

  

Authors:	Goldstein, D. A.; Ratain, M. J.; Saltz, L. B.
Title:	Weight-based dosing of pembrolizumab every 6 weeks in the time of COVID-19
Journal Title:	JAMA Oncology
Volume:	6
Issue:	11
ISSN:	2374-2437
Publisher:	American Medical Association
Date Published:	2020-11-01
Start Page:	1694
End Page:	1695
Language:	English
DOI:	10.1001/jamaoncol.2020.2493
PUBMED:	32459313
PROVIDER:	scopus
DOI/URL:	https://www.scopus.com/inward/record.uri?eid=2-s2.0-85085762124&doi=10.1001%2fjamaoncol.2020.2493&partnerID=40&md5=dc6ed0880ead6ac95fcfff5a666db2c4
Notes:	Note -- Export Date: 1 March 2021 -- Source: Scopus

https://synapse.mskcc.org/synapse/works/has_related_data_chk/177521